Alterity Therapeutics (ATHE) Accounts Payables (2009 - 2025)

Alterity Therapeutics' Accounts Payables history runs 16 years deep, the most recent figure standing at $1.0 million for Q4 2025.

• In Q4 2025, Accounts Payables fell 21.85% year-over-year to $1.0 million; the TTM figure through Dec 2025 stood at $1.0 million (down 21.85% YoY), while the FY2025 annual figure was $1.6 million, up 3470.23% from the prior year.
• Accounts Payables was $1.0 million for Q4 2025 at Alterity Therapeutics, down from $1.6 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $3.6 million in Q2 2022 to a low of $1.0 million in Q4 2025.
• Historically, Accounts Payables has averaged $2.3 million across 5 years, with a median of $2.3 million in 2021.
• The sharpest annual moves came in 2022 and 2025: Accounts Payables surged 88.8% in 2022, then tumbled 45.83% in 2025.
• A 5-year view of Accounts Payables shows it stood at $2.3 million in 2021, then increased by 27.9% to $2.9 million in 2022, then declined by 19.05% to $2.4 million in 2023, then slumped by 43.27% to $1.3 million in 2024, then dropped by 21.85% to $1.0 million in 2025.
• The last three Accounts Payables figures came in at $1.0 million (Q4 2025), $1.6 million (Q2 2025), and $1.3 million (Q4 2024), per Business Quant data.